In this episode of The Syneos Health Podcast: Conversations on Commercialization, Commercial VP and Host, Tyler Cowan, speaks with Tim Jones, SVP, Commercial Excellence and Business Intelligence and Melissa Bojorquez, VP, AI Customer Engagement, about how artificial intelligence (AI), data and technology are reshaping biopharmaceutical commercialization.

The conversation explores practical applications of AI in pharma commercialization, including smarter targeting, more personalized healthcare professional (HCP) engagement, faster decision-making and new approaches to commercial deployment. Tim and Melissa also share examples of how AI-enabled strategies can improve productivity, optimize channel mix and uncover growth opportunities in areas such as rare disease.

Listeners will hear how Syneos Health is moving AI beyond experimentation to support measurable business impact—and why the opportunity is less about replacing people and more about helping commercial teams work smarter, respond faster and focus on higher-value customer needs.

This episode is a preview of the practical AI, HCP engagement and commercialization strategies we’ll present at Fierce Pharma Week 2026, including how AI can support more personalized engagement, smarter next best action and accelerated commercial growth.

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.

If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub.

Like what you’re hearing? Be sure to rate and review us!

We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com.

In this episode of The Syneos Health Podcast: Conversations on Commercialization, Tyler Cowan, VP, Commercial is joined by colleagues from our team in the UK, Dr. Natalia Barkalina, Medical Director and Gareth Powell, Clinical Recruitment and Retention Strategist, to discuss why patient-centered communication is essential to improving clinical trial awareness, recruitment and engagement, particularly for small and mid-size biotech companies competing for patient and investigator attention.

Listen and gain a clear understanding of how integrated, patient-centered communications can help clinical trials cut through the noise, build trust with key audiences and create stronger foundations for commercialization.

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.

If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub.

Like what you’re hearing? Be sure to rate and review us!

We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com.

In this episode, recorded on the ground at Asembia's AXS26 Summit, host Chris Van Denburg sits down with George Jones, Chief Commercial Officer at Biofrontera, to explore how artificial intelligence (AI) is helping smaller biopharmaceutical companies operate more efficiently while maintaining quality, oversight and accountability. George shares how Biofrontera is leveraging AI to streamline commercial operations, automate workflows and generate actionable insights that support smarter, faster decision-making.

The conversation explores practical applications of AI across commercial analytics, territory planning, reimbursement analysis and customer service, highlighting how lean organizations can create greater scale without adding headcount. George explains why AI should be viewed as an assistant that enhances human expertise rather than replaces it, enabling teams to focus on higher-value work while improving operational efficiency and patient access.

The episode also examines why responsible AI adoption requires strong governance. George discusses the importance of keeping a "human in the loop" to validate AI-generated insights, mitigate risks such as hallucinations and confirmation bias, and ensure technology supports sound business decisions that ultimately benefit healthcare providers and the patients they serve.

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.

If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub.

Like what you’re hearing? Be sure to rate and review us!

We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com.